Your best investor pitch is the one you'll never hear

Ask a DeepTech founder at Seed or Series A what they are most anxious about before a raise, and almost all of them point at the technology. Is the demonstration robust enough. Will the data survive a technical partner's scrutiny. Can we prove, beyond argument, that the science does what we say it does. So the weeks before a round pour into exactly that: the demo, the data room, the technical appendix that answers the question they are certain decides everything.

But they are answering the stated question, not the real one. Yes, the science matters. But an experienced early-stage investor is not, at the very beginning of this conversation, trying to satisfy themselves that the tech works. They have provisionally granted it, because backing that kind of bet is the entire reason their fund exists. What they are testing, first and hardest, is whether anyone will actually need the thing you are building once it does.

And they do not test that by asking you. They test it by asking your early adopters, in conversations you are not in, cannot hear, and cannot stage-manage. You will have pitched. It will have gone well, or seemed to. Then, after your meeting and well before any term sheet, the most consequential conversation of your raise takes place in a room you have just left.

What the investor is actually buying

Unlike SaaS markets, an early-stage DeepTech investor is rarely assessing commercial momentum. At Seed, at Series A, and at the kind of Series B that follows a long technical gestation, there may be almost no revenue to examine, and the product is still taking shape. This is a different exercise entirely from growth-stage investing, where by the later end of Series B and beyond the product is proven and the question has become commercial scaling. Here, in the early stages, the investor is buying conviction about something that has few metrics attached.

So they are assessing the precursor to traction, which is evidence of relevance: proof that the technology addresses a real problem, in a real setting, that provides an aperture into a wider market. The classic DeepTech failure is precisely the absence of that proof: teams that spend years perfecting the technology, raise on the strength of the science, and only then discover the mainstream customer (per Geoffrey Moore’s definition) had no urgent problem, no budget, or no way to absorb what was built.

The same trap shows up in how founders value themselves, with technical teams routinely overestimating the worth of their intellectual property before they have any real evidence of demand. This is the DeepTech founder's blind spot in one line. You think you are being asked whether it works. You are being asked whether it matters.

That is why the early adopter conversation carries the weight it does. It is the one source that can speak to relevance from inside a real application, which is a vantage point no slide of yours can occupy.

Why the customer, and not you

When an investor calls your early adopter, they are not collecting a testimonial. They are running what one venture investor who does it routinely calls the most valuable step in diligence, the one that gives feedback no founder and no deck can supply. A committed early adopter took your earliest, roughest version, the one that barely earns the word product, and engaged with it seriously enough to form a view. They know where it works and where it does not. They understand the roadmap and whether it leads somewhere that matters to them.

Asked the right questions, that customer can tell an investor whether the technology is genuinely relevant to a problem worth solving, and can describe the wider opportunity as only someone living the problem can. The investor trusts it precisely because you did not script it.

What that early adopter is not doing is certifying that your product works. This is the distinction founders often miss. The early customer is not signing off a finished technology, and an experienced investor is not asking them to. A definitive verdict on the product belongs later, when the company is crossing into the mainstream market where the buyer will have no tolerance for rough edges. What the early adopter offers now is narrower and, at this stage, more valuable: first-hand corroboration that you are building something that should open up a huge market.

The early adopter you chose, and why you may have chosen wrong

Here's the rub for DeepTech founders: the customer who can quietly cost you the round was chosen long before the raise, and often for the wrong reasons.

Founders tend to select early adopters for ease. The most collaborative. The quickest to say yes. The one willing to pay a small pilot fee. None of those qualities is the one that counts when an investor comes calling. What counts is whether the customer engaged deeply enough to speak with authority about relevance and trajectory, and whether they sit close enough to the centre of your market to bring gravitas to that conversation. An early adopter without that standing simply cannot give the investor the evidence they came for, however enthusiastic the endorsement.

The trap is that this mistake is almost invisible when you make it. Choosing a friendly, easy early adopter feels like progress, and it is: you have a paying customer and a reference on the slide. The cost only appears much later, in the investor's call, when a customer who was never quite representative gives an answer that does not translate, and the round quietly loses momentum for reasons you never see stated. You cannot go back and choose differently at that point. This was a long-lead-time funding decision that you missed and probably can't recover from.

The field is smaller than you think

There is a further reason the choice matters so much in DeepTech specifically, and it cuts against the SaaS intuition. A software investor can ring twenty users to triangulate. You may have three early adopters in total, sometimes fewer, often in a field small enough that the serious investors and the serious customers already know one another. In that world the informal read travels regardless: an investor forms a view of you not only from the references you present, but from a quiet word in a community where reputations spread quickly and stick.

This does not replace the formal reference conversation, which remains where conviction is won or lost. But it raises the cost of every early relationship, because in a small field each customer, partner, or even supplier, can become a witness.

Build the reference before you need it

Which turns the whole exercise from a fundraising task into a company-building one. If the decisive asset in an early DeepTech raise is a knowledgeable, representative customer who will vouch for the relevance of what you are building, and if the field is small enough that there will only ever be a few of them, then that asset cannot be assembled in the weeks before a round. It is built in how you choose your early adopters, and how seriously you treat them, long before fundraising enters your mind.

Last week we wrote about the long timelines DeepTech founders live with, and the discipline of not letting the slow clock of the science become an excuse for a slow company. This is the same discipline aimed at a different target: not letting the sheer importance of the science convince you that the science is what you are being judged on. Choose the customer who is representative over the one who is easy. Do the unglamorous work of making an early adopter genuinely successful, not merely genuinely friendly. It will feel, at the time, like a commercial decision or a product one. It is quietly also the most important fundraising decision you will make, and you will make it a year before it counts.

Takeaways

The reveal beneath all of this is a single reframe. Your early raise is not decided by whether you convinced the investor the technology works. It is decided by what a customer says about its relevance in a conversation you are not part of. Prepare accordingly, which means preparing far earlier than the round.

Understand that the early-stage investor initially grants the science and gates on the market. Understand that the early adopter speaks to relevance and direction, not to a finished product. And understand that the customer best placed to speak for you is one you will have chosen long before the raise, on ordinary commercial grounds, without any idea they would one day be the person an investor trusts most. That is exactly why the choice deserves far more thought than founders tend to give it.

So, well before your next raise, ask yourself this question: When an investor sits down with your most important early adopter and asks whether what you have built is relevant, what will that customer say? It will not matter that you won’t be in the room, because by then the die is cast. The work is making sure that, long before the question is asked, you chose the person who will give the answer you need.

 
Let's talk.